Loading…
← CockpitCompetitor Analysis › HNGE Hinge Health, Inc. Class AOpen in the cockpit ↗

Hinge Health, Inc. Class AHNGECompetitor analysis, valuation and peers

United States · USD·Information Technology›Packaged Software

US digital health company providing app-based physical therapy and musculoskeletal (MSK) care programs, mainly paid for by employers.

Momentum leader 98
Mkt cap
$9.31B
US dollars, full cap
Free float
85%
of shares outstanding
$/day
$219M
20-day average traded
Fwd P/E
39.2×
forward earnings
ROIC−WACC
n/a
WACC 10.9%
Hurdle
-16 pp
Req g minus delivered
Next earnings
90 days
16 Feb 2027
Close · USD$114.53
1D+0.1%
1W-5.9%
1M+6.5%
3M+33.8%
6M+109.2%
YTD+146.6%
1Y+180.4%
ATR %4.9%
Beta1.16
52w lowhigh9.4% off high

What Hinge Health does

US digital health company providing app-based physical therapy and musculoskeletal (MSK) care programs, mainly paid for by employers.

Employers and health plans pay Hinge for their members' access, with fees tied partly to how many members actually take up the programme and to meeting savings targets, so Hinge shares the risk if it fails to cut medical costs. Members pay nothing because the employer funds access.

Products and services

  • App-based physical therapy programs
  • Wearable motion sensors
  • Surgery/care navigation support

Customers

  • Self-insured employers
  • Health plans/payers

Where it sits in the supply chain

  • Digital health/software
  • Digital musculoskeletal (MSK) therapy
  • Employers/health plans, patients with…

What could go right

  • Employer digital MSK benefit adoption growth
  • Expansion into adjacent chronic condition care

What could go wrong

  • Employer benefits budget cyclicality
  • Competition from other digital MSK/health point solutions

Moat: narrow (data, switching costs, customer qualification). Clinical outcomes data and employer benefit-plan integration create switching costs once adopted as a benefit.

Headquarters: San Francisco, California, US · Founded: 2014 · Employees: 143

Named competitors

  • Sword Health private or unlisted
  • Omada Health OMDA
  • Kaia Health private or unlisted
  • Traditional in-person physical therapy providers private or unlisted

Hinge Health at a glance

Size Hinge Health (HNGE) is a United States Information Technology company (Packaged Software) with a market value of $9.31B, the 811th largest of 3,085 United States companies the cockpit tracks. Shares closed at $114.53 on 18 Nov 2026.

Performance Over six months the shares gained 109.2%, against +18.9% for the median peer and -2.2% for the United States market (cap-weighted) — highest of 21 in its peer set.

Growth Revenue grew 49.9% over the last twelve months (peer median +19.1%); the operating margin is 19.4% (peer median 9.6%).

Valuation It trades at 39.2× forward earnings against a peer median of 32.6× (7th most expensive of 19).

Price implies For today's price to make sense, revenue must grow about 34% a year for seven years (Req g). Recent delivered growth is +50%, so the hurdle is -16 pp: the price already allows for a slowdown.

Short interest Short interest is 8.0% of the free float (30 Oct 2026).

Next results Next results expected around 16 Feb 2027 (exchange calendar; dates can move).

Relative performance

10015020021 May 202621 Aug 202618 Nov 2026HNGE 208Peer median 120
Six months, rebased to 100: Hinge Health against the median of its 20 peers (local-currency closes).

Hinge Health financials

Reported figures in USD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023
Revenue$801M$588M$390M$293M
Revenue growth—+51%+33%—
Gross profit$687M$468M$301M$194M
EBITDA$161M-$536M-$18.5M-$125M
Net income$166M-$424M-$11.9M-$108M
Free cash flow$315M$165M$45.2M-$68.5M
Capital expenditure$7.69M$6.06M$3.77M$4.62M
Total debt$33.9M$8.04M$11.1M$15.7M

Quarterly statements and history in the cockpit →

Hinge Health competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%0%+50%+100%-20%0%+20%FIGSNAPDOCNPCTYOFSSXRONTSKESTCYMMZETAHUBSWTC9684301638S6013604716PAYCTTANDSGHNGE6-month return →1-month return →
Up and to the right = strong over both horizons. Hinge Health is the large dot.

Fundamentals: revenue growth against valuation

+20%+40%+60%0×50×100×150×FIGSNAPDOCNPCTYOFSSXROESTCYMMZETAHUBSWTCS601360PAYCTTANDSGHNGERevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Hinge Health is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%+60%0%25%50%FIGSNAPDOCNPCTYOFSSXROESTCYMMZETAHUBSWTC9684301638S6013604716HNGEGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Hinge Health is the large dot.

Hinge Health competitors and peer comparison

Head to head with its named competitors (HNGE vs OMDA)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Hinge Health HNGE$9.31B+109%+50%19%39.2×34.3%
Omada Health OMDA$817M-20%+43%2%28.3×44.4%

How Hinge Health compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Hinge Health against its 20 peers (data as of 18 Nov 2026)
MeasureHNGEPeer medianRank in peer set
1-month return+6.5%-3.8%5th highest of 21
6-month return+109.2%+18.9%highest of 21
Distance from 52-week high-9.4%-28.8%4th highest of 21
Revenue growth (TTM)+49.9%+19.1%2nd highest of 21
Operating margin19.4%9.6%9th highest of 21
Forward P/E39.2×32.6×7th most expensive of 19
Growth the price implies (Req g, 7 yrs)34.3%20.0%5th most demanding of 20
Growth delivered (Del g)+49.9%+23.1%2nd highest of 20
Hurdle (Req g minus delivered)-15.6 pp-5.9 pp5th least demanding of 20
EV / EBITDA56.3×18.6×most expensive of 13
Net debt / EBITDA-1.6×-0.4×4th least indebted of 14

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Hinge Health HNGEUnited States$9.31B+109%+50%19%39.2×34.3%+49.9%
Figma FIGUnited States$9.28B-23%+44%-41%50.4×21.4%+44.4%
Snap SNAPUnited States$9.39B-3%+14%-2%35.5×3.9%+18.8%
DigitalOcean DOCNUnited States$9.51B-50%+28%12%49.0×44.4%+23.1%
Paylocity PCTYUnited States$9.09B+55%+11%22%18.5×2.8%+22.7%
Oracle Financial Services Software OFSS.NSIndia$9.05B0%+28%52%21.6×21.1%+9.0%
Xero XRO.AXAustralia$9.04B+4%+33%9%50.1×33.4%+25.3%
Netskope NTSKUnited States$9.60B+100%+30%-94%n/an/an/a
Elastic ESTCUnited States$8.80B+50%+16%-1%23.5×12.7%+23.4%
Full Truck Alliance Co. Ltd. Sponsored ADR YMMUnited States$8.68B-1%+9%34%11.7×-12.1%+36.0%
Zeta Global ZETAUnited States$8.68B+85%+41%5%26.4×43.8%+28.8%
HubSpot HUBSUnited States$10.0B+1%+20%5%12.8×20.0%+28.8%
Wisetech Global WTC.AXAustralia$10.4B+26%+71%31%33.3×31.0%+32.3%
Square Enix 9684.TJapan$8.31B+35%+9%20%32.0×-3.9%-2.1%
CSG Digital Power Grid Research Institute 301638.SZChina$8.31B-41%+18%10%n/a17.5%+8.2%
SentinelOne SUnited States$8.12B+30%+21%-26%58.6×56.1%+60.8%
360 Security Technology 601360.SSChina$8.00B-29%+7%-4%160.0×52.2%-5.7%
Oracle Corporation Japan 4716.TJapan$7.97B+13%+10%32%17.7×-7.0%+6.5%
Paycom Software PAYCUnited States$11.0B+76%+9%33%16.3×2.4%+19.5%
ServiceTitan TTANUnited States$7.87B+25%+23%-13%55.1×21.2%+27.1%
Descartes Systems DSG.TOCanada$7.78B+31%+12%33%37.3×4.5%+16.8%

Questions

Who are Hinge Health's main competitors?
Named competitors: Sword Health (private or unlisted), Omada Health (OMDA), Kaia Health (private or unlisted), Traditional in-person physical therapy providers (private or unlisted). The cockpit's measured peer set (industry) also includes Figma (FIG), Snap (SNAP), DigitalOcean (DOCN), Paylocity (PCTY), Oracle Financial Services Software (OFSS.NS), Xero (XRO.AX).
Is Hinge Health expensive compared with its peers?
On forward p/e it trades at 39.2× against a peer median of 32.6×, 7th most expensive of 19 in its peer set. For today's price to make sense, revenue must grow about 34% a year for seven years (Req g). Recent delivered growth is +50%, so the hurdle is -16 pp: the price already allows for a slowdown.
How has Hinge Health stock performed?
Over six months to 18 Nov 2026 the shares returned +109.2% against +18.9% for the median peer; over one year +180.4%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.